
Provider review
BluefitMD review
A real FDA warning letter, and a LegitScript badge that fails to verify.
FDA's own Feb 20, 2026 letter (MARCS-CMS 721446) cites BluefitMD-branded product labels that falsely suggest BluefitMD itself is the compounder, plus "same active ingredient as Ozempic®/Wegovy®" and "Mounjaro®/Zepbound®" claims FDA says imply approval. Separately, and independently found: the LegitScript seal embedded on every page (ID 38397132) returns HTTP 403 at LegitScript's own CDN, the same failure mode as an invented ID.
Transparency scorecard
2 of 4 disclosed openly
What BluefitMD discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Disclosed
Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
Tirzepatide: BluefitMD's own site-wide lead-generation funnel (app.bluefitmd.com/tirzepatide) headlines "Tirzepatide Treatments As Low As $225/mo." — the 12-month prepay rate for its lowest (2.5mg) dose. Sermorelin: its own /sermorelin page and checkout funnel both headline "$249/mo" directly, though a separate sitewide nav teaser elsewhere advertises "As low as $159/mo* *With a 12-month package" instead.
What you actually pay, month to month
Tirzepatide: $325/month at the lowest (2.5mg) dose, confirmed on BluefitMD's own dose-specific "Monthly Membership (No Commitment)" checkout page — scaling to $475 (7.5mg/10mg), $675 (12.5mg), and $775/month (15mg), each confirmed the same way. Sermorelin: $249/month, stated identically as the standing "Monthly Membership" rate on both the marketing page and the checkout funnel — genuinely the true price, not a promo.
The commitment trap
Tirzepatide's headline is the 12-month prepay rate; the true no-commitment monthly price is 44% to 244% higher depending on dose. Sermorelin's own product page and checkout funnel are honest about the $249/mo standing price — the trap there is a separate sitewide nav banner (not the product page itself) advertising the cheaper prepay tier as if it were the going rate.
Money you will meet later
- Every tirzepatide dose tier's checkout page shows an identical "SAVE $X" discount badge ($24/mo monthly, $124 for 3 months, $444 for 6 months, $1,488 for 12 months) regardless of dose — and on every dose tier checked, that badge amount does not match the struck-through "before" price and the current "after" price shown directly beside it.
- Its own Return & Refund Policy states, "Due to the nature of our products, all sales are final," with a narrow 7-day exception only for damaged shipments — separate from the "cancel your membership anytime" language that stops future billing.
Checked live on BluefitMD's own site at https://app.bluefitmd.com/compounded-tirzepatide-package25 in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off BluefitMD's own public pages on the date shown, not from a third-party comparison table.
The bottom line
BluefitMD LLC (Sunbiz #P24000054174, a real Florida LLC active since August 2024, based at 1841 Lakewood Ranch Blvd, Lakewood Ranch, FL — the exact address its own FDA letter was mailed to) is a real, live telehealth clinic selling compounded tirzepatide and semaglutide, compounded sermorelin, NAD+/MICC+B12/methylene blue, and testosterone therapy, with checkout running through a separate app.bluefitmd.com funnel. Before researching pricing, this review checked for the same kind of finding that disqualified a peer from this same FDA enforcement wave (MEDVi, excluded from this site entirely for independently-documented deepfaked patient photos and fabricated physician personas) — no independent journalism names BluefitMD, no fabricated-persona pattern was found, and its own site carries no "individuals may be actors" hedge anywhere, only a standard illustrative-photo disclaimer on medication-vial images. That clears the bar this site draws between a disclosable knock and a disqualifying one. What remains is a real, dated FDA warning letter (MARCS-CMS 721446, February 20, 2026) citing two things: product labels pictured on BluefitMD's own site that identified "BluefitMD" as the compounder when it is not, and marketing claims — "Compounded Semaglutide (the same active ingredient as Ozempic® and Wegovy®)" and "Compounded Tirzepatide (the same active ingredient as Mounjaro® & Zepbound®)" — that FDA states imply the products were FDA-approved or evaluated for safety and effectiveness when they were not. Both claims were confirmed verbatim on a Wayback Machine snapshot from February 6, 2026; the live compounded-tirzepatide and compounded-semaglutide pages both 404 today, and both are still live links in the site's own primary navigation. Independent of the FDA letter, this review found its own LegitScript seal does not check out (see signal), and its own Policies page states pricing "remains consistent regardless of dosage adjustments" — contradicted by its own checkout data, where the same tirzepatide product's true no-commitment monthly price scales from $325 at the lowest dose to $775 at the highest, more than doubling, with an identical "SAVE $X" badge shown at every dose tier regardless of the different prices around it.
BluefitMD appears on our sermorelin provider ranking and our tirzepatide provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want a direct, unhedged 503A pharmacy category claim — BluefitMD's own About and Safety Info pages both state it plainly, unlike several peers on this board that hedge between 503A and 503B.
- You've read BluefitMD's FDA warning letter and its current site side by side and are satisfied the specific mislabeled-compounder claim no longer appears (the live compounded-tirzepatide/semaglutide pages are gone entirely, though the products are still sold via a different checkout path).
- You're pricing sermorelin specifically — its $249/mo standing price is genuinely undisguised, agreeing across its own product page and its own checkout funnel, a cleaner story than its own tirzepatide listing.
Look elsewhere if
- An open FDA warning letter over how a company marketed compounded drugs is a hard line for you, regardless of what a live check finds today.
- You're budgeting off BluefitMD's own "As low as $225/mo" tirzepatide headline — the real no-commitment price, by dose, is $325 to $775/month, and its own Policies page's claim that price doesn't vary by dose is directly contradicted by its own checkout pages.
- You check a LegitScript badge before trusting it — BluefitMD's own seal ID returns "Access Denied" at LegitScript's own CDN, the same failure as a badge that was never real.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what BluefitMD bundles in, and what it does not.
Clinician consult
Included
Every plan requires "a licensed medical provider" review before a prescription issues, per its own 4-step process ("How it works") shown on both the tirzepatide and sermorelin pages.
Bloodwork / labs
Not stated on site
— no bloodwork requirement, cost, or cadence is published anywhere on the pages checked.
Follow-ups and dose changes
Described only generically: "Benefit from ongoing care,…
support, and adjustments to your plan," with no specific visit cadence stated.
Human support
No dietitian, nurse, or structured coaching program is named…
anywhere on the tirzepatide or sermorelin pages. Tirzepatide memberships include a "Personalized Wellness Blueprint" — a physician-reviewed lifestyle guide, not a dietitian or coach.
Injection supplies
Itemized for sermorelin: "Includes a 5mL (6mg) vial with a full…
home-use kit," per its own /sermorelin page. Tirzepatide plans similarly state supplies and instructions are included, per its own site copy, without itemizing individual items.
Shipping
Free
"Fast, tracked shipping at no extra cost" (sermorelin) and "Free priority shipping straight to your door—no hidden fees" (tirzepatide), per each product's own page. Its Policies page separately states orders ship UPS, Monday-Friday, 1-2 business days after payment.
Who fills it, and who's watching
The pharmacy
"503A," stated directly and unhedged on two separate pages. BluefitMD's own /about page: "BluefitMD connects you with licensed, U.S.-based 503A pharmacies that are state-regulated and audited for safety and quality." Its /safety-info page repeats the category for the tirzepatide product specifically: "Prepared by licensed U.S.-based 503A pharmacies." No specific pharmacy is ever named by name anywhere on the site — the Policies page instead refers only to "a licensed pharmacy in our network."
Oversight
Included. Every plan requires "a licensed medical provider" review before a prescription issues, per its own 4-step process ("How it works") shown on both the tirzepatide and sermorelin pages. Described only generically: "Benefit from ongoing care, support, and adjustments to your plan," with no specific visit cadence stated.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
Not published as a list, and the site's own pages disagree with each other. BluefitMD's /about page markets a "nationwide network of licensed providers and pharmacies," and its checkout intake collects a "State" field with no stated restriction — but the only document on the site that states an actual state SCOPE, its own HIPAA Compliant Privacy Policy PDF, says twice that it covers "Patients in Florida and New York" specifically. That document also contains an unedited template artifact ("Re acknowledges and respects these rights," with no company name filled in), so the two-state scope reads more like boilerplate than a real 48-state exclusion — but it is the only page on the site that states any scope at all.
The honest cons
The part they would rather you skipped
FDA issued BluefitMD a warning letter (MARCS-CMS 721446, February 20, 2026, Center for Drug Evaluation and Research), addressed to BluefitMD at 1841 Lakewood Ranch Blvd, Lakewood Ranch, FL 34211 — the identical address independently confirmed as BluefitMD LLC's own Florida corporate registration. The letter states FDA reviewed bluefitmd.com in December 2025 and found two things misbranded under FDCA §502(a)/§502(bb): first, "the compounded semaglutide and tirzepatide products displayed on your website identify 'BluefitMD' on the pictured label, suggesting BluefitMD is the compounder of those drugs when in fact it is not"; second, the site carried the claims "Compounded Semaglutide (the same active ingredient as Ozempic® and Wegovy®)" and "Compounded Tirzepatide (the same active ingredient as Mounjaro® & Zepbound®)," which FDA says falsely imply the products were FDA-approved or evaluated for safety and effectiveness when they were not. Both quoted claims were independently confirmed verbatim on a Wayback Machine snapshot of bluefitmd.com/compounded-tirzepatide dated February 6, 2026 — after FDA's December 2025 site review and just before the letter. Today, both bluefitmd.com/compounded-tirzepatide and bluefitmd.com/compounded-semaglutide 404 on the live site, even though both remain live links in BluefitMD's own primary navigation on every page checked, and even though the products themselves are still sold through a separate app.bluefitmd.com checkout funnel found independently of the marketing site's own broken links. Independent of the FDA letter: BluefitMD's own footer embeds a LegitScript seal widget (ID 38397132) on every page checked; that ID returns HTTP 403 "Access Denied" at LegitScript's own CDN, the identical failure mode this review confirmed for an invented ID, and different from two known-good control IDs elsewhere on this roster (NexLife's 46376918, Hone Health's 10842626, both HTTP 200).
- FDA warning letter (MARCS-CMS 721446, Feb 20, 2026) over a mislabeled-compounder claim and FDA-approval-implying marketing language — see this review's knock for the full, independently-verified finding.
- Its own footer LegitScript seal (ID 38397132) returns HTTP 403 "Access Denied" at LegitScript's own CDN — the same failure as an invented ID.
- Its own Policies page states pricing "remains consistent regardless of dosage adjustments" — contradicted by its own checkout data, where the true tirzepatide price more than doubles by dose ($325 to $775/month), with an identical, mathematically-wrong "SAVE $X" badge shown at every dose tier.
- Both "Compounded Semaglutide" and "Compounded Tirzepatide" — the exact two products its FDA letter is about — are live links in its own primary navigation that currently 404, even though the products remain purchasable through a different checkout path.
- No comprehensive state list is published; the only document on the site stating any state scope at all (its HIPAA Privacy Policy) names just Florida and New York, contradicting its own "nationwide network" marketing language.
- No pharmacy is named by name anywhere on the site — only the 503A category, and only "a licensed pharmacy in our network."
None of this is unique to BluefitMD — the whole category shares it.
How it compares
The providers we rank on our sermorelin provider ranking — the most specific board BluefitMD sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- EHEOS HealthNames five 503A pharmacies — but its own legal pages disagree on HIPAA.
- PLPlexusDxPriciest starting-price seller; the only one admitting it's not FDA-approved.
- StackMDReal dose-tier pricing — but its sermorelin page quotes a price nothing sells at.

- Precision TelemedNames its actual compounding pharmacy directly on its own product pages.

- NuBloomFlat, checkable pricing — undercut by its own FAQ and an unfilled legal clause.

- CoreAge RxA low advertised floor on both boards, with no named pharmacy and no ceiling.

- LILibertyStates 503B, not 503A — but its own price table doesn't match its own cart.
- Strut HealthAn FDA warning letter over labeling, plus an auto-refill price on every product.

8 more providers rank on our sermorelin provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect BluefitMD's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on BluefitMD's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.